These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1338002)

  • 21. Sedimentation rate, leucocytes, platelet count and haemoglobin in bronchial carcinoma: an epidemiological study.
    Gislason T; Nõu E
    Eur J Respir Dis; 1985 Feb; 66(2):141-6. PubMed ID: 2982631
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Survival and prognostic factors in lung cancer patients treated in phase I trials: Japanese experience.
    Yamamoto N; Tamura T; Fukuoka M; Saijo N
    Int J Oncol; 1999 Oct; 15(4):737-41. PubMed ID: 10493956
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Prognostic factors in the surgical treatment of lung cancer].
    Davydov MI; Polotskiĭ BE; Malaev SG; Smirnova EA; Machaladze ZO
    Khirurgiia (Mosk); 1996; (1):13-6. PubMed ID: 8683911
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Prognostic factors in unresectable lung cancer].
    Urata A
    Gan To Kagaku Ryoho; 1988 Jul; 15(7):2035-42. PubMed ID: 2840034
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Comparative study of serum lipid-bound sialic acid and carcinoembryonic antigen in patients with lung cancer].
    Zhu X
    Zhonghua Jie He He Hu Xi Za Zhi; 1990 Feb; 13(1):25-7, 61. PubMed ID: 2165867
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Correlation between the tumor marker Pro-GRP and prognosis in patients with small-cell lung cancer].
    Tsuchiyama T; Kawahara M; Naka N; Yamamoto S; Nakao M; Kamimori T; Okada T; Atagi S; Ogawara M; Furuse K
    Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Jun; 35(6):616-21. PubMed ID: 9294294
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma calcitonin in small cell lung cancer: prognostic significance.
    Sappino AP; Carter S; Ellison M; Smith IE
    Br J Cancer; 1983 Dec; 48(6):881-2. PubMed ID: 6317005
    [No Abstract]   [Full Text] [Related]  

  • 28. [Polychemoradiation treatment of non-small cell lung cancer].
    Linchenko IF; Danil'ian Vm
    Med Radiol (Mosk); 1985 Aug; 30(8):64-9. PubMed ID: 2993782
    [No Abstract]   [Full Text] [Related]  

  • 29. [Radioimmunologic evaluation of the prognosis and effective therapy of patients with small cell lung cancer].
    Ausekar BP6 ; Smirnova KD; Gromova NV; Perevodchikova NI
    Med Radiol (Mosk); 1985 Nov; 30(11):18-20. PubMed ID: 2999553
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The prognostic significance of the direct effect in the conservative treatment of small-cell lung cancer].
    Boĭko AV
    Med Radiol (Mosk); 1991; 36(11):24-6. PubMed ID: 1658530
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Photodynamic therapy in lung cancer].
    Kato H; Konaka C; Nishimiya K; Takahashi H; Kitoh T; Aizawa K; Hayata Y
    Gan No Rinsho; 1985 May; 31(6 Suppl):690-6. PubMed ID: 2993693
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of adjuvant therapy after resection of T1 N1 M0 and T2 N1 M0 non-small cell lung cancer.
    Ferguson MK; Little AG; Golomb HM; Hoffman PC; DeMeester TR; Beveridge R; Skinner DB
    J Thorac Cardiovasc Surg; 1986 Mar; 91(3):344-9. PubMed ID: 3005776
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Markov model and markers of small cell lung cancer: assessing the influence of reversible serum NSE, CYFRA 21-1 and TPS levels on prognosis.
    Boher JM; Pujol JL; Grenier J; Daurès JP
    Br J Cancer; 1999 Mar; 79(9-10):1419-27. PubMed ID: 10188885
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Invited commentary.
    Grannis F
    Ann Thorac Surg; 2006 Jan; 81(1):297. PubMed ID: 16368384
    [No Abstract]   [Full Text] [Related]  

  • 35. [Level of double bonds in lipids in human plasma and erythrocytes].
    Korman DB; Potapov SL
    Patol Fiziol Eksp Ter; 1995; (4):7-10. PubMed ID: 8700600
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Factors affecting the prognosis in patients with primary lung cancer and brain metastases].
    Yurdakul AS; Halilçolar H; Oztürk C; Tatar D; Karakaya J
    Tuberk Toraks; 2006; 54(3):235-42. PubMed ID: 17001540
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circulating blood RNA in lung cancer.
    Behera D; Mallik SK; Dani HM; Gumbhir K
    J Assoc Physicians India; 1986 Aug; 34(8):579-80. PubMed ID: 2432053
    [No Abstract]   [Full Text] [Related]  

  • 38. Pretreatment serum albumin concentration and lactic dehydrogenase activity as prognostic factors in patients with small cell lung cancer.
    Ohnoshi T; Hiraki S; Nakata Y; Ozawa S; Tamura T; Seto T; Miyai M; Kawahara S; Numata T; Kimura I
    Acta Med Okayama; 1982 Dec; 36(6):487-90. PubMed ID: 6297259
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic factors in surgical treatment of bronchogenic carcinoma.
    Lee YT
    Surg Gynecol Obstet; 1972 Dec; 135(6):961-75. PubMed ID: 4343701
    [No Abstract]   [Full Text] [Related]  

  • 40. Elastin metabolism parameters in sera of patients with lung cancer.
    Gmiński J; Mykala-Cieśla J; Machalski M; Drózdz M
    Neoplasma; 1993; 40(1):41-4. PubMed ID: 8394514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.